Details of the Drug Formulations

General Information of Drug (ID: DM6D7N8)

Drug Name
Propylthiouracil Drug Info
Synonyms
propylthiouracil; 51-52-5; 6-Propyl-2-thiouracil; Propacil; Prothyran; Prothiurone; Procasil; Propycil; Thiuragyl; Protiural; Prothiucil; Prothycil; Propyl-Thiorist; Propyl-Thyracil; 2-Mercapto-6-propylpyrimidin-4-ol; 6-N-Propylthiouracil; Propythiouracil; Propilthiouracil; Propyl-Thiorit; Propylthiorit; 6-Propylthiouracil; Propylthiouracile; Thyreostat II; 6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one; Propiltiouracilo; 6-N-Propyl-2-thiouracil; 6-Thio-4-propyluracil; PTU (thyreostatic); Propylthiouracilum; 4-Propyl-2-thiouracil; Procasil; Propiltiouracile; PROPYL THIOURACIL; Propiltiouracile [DCIT]; Thyreos tat ii; HC210060; Propiltiouracilo [INN-Spanish]; Propylthiouracil (TN); Propylthiouracile [INN-French]; Propylthiouracilum [INN-Latin]; Ptu(thyreostatic); T0517-6237; Thyreostat propyl-thyracil; Propylthiouracil [INN:BAN:JAN]; Propylthiouracil (JP15/USP/INN); 2,3-Dihydro-6-propyl-2-thioxo-4(1H)-pyrimidinone; 2-Mercapto-4-hydroxy-6-n-propylpyrimidine; 2-Mercapto-6-propyl-4-pyrimidone; 2-Mercapto-6-propylpyrimid-4-one; 2-Thio-4-oxo-6-propyl-1,3-pyrimidine; 2-Thio-6-propyl-1,3-pyrimidin-4-one; 4-Hydroxy-2-mercapto-6-propylpyrimidine; 6 Propyl 2 Thiouracil; 6-(n-Propyl)-2-thiouracil; 6-Prop yl-2-thiouracil; 6-Propil-tiouracile; 6-Propil-tiouracile [Italian]; 6-Propyl-2-thio-2,4(1H,3H)-pyrimidinedione; 6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione; 6-n-PROPYL-2-MERCAPTO-4-HYDROXYPYRIMIDINE; 6-propyl-2 thiouracil; 6-propyl-2-sulfanylidene-1H-pyrimidin-4-one; 6-propyl-2-sulfanylidene-2,3-dihydropyrimidin-4(1H)-one; 6-propyl-2-thiopyrimidine-2,4(1H,3H)-dione; Propyl thiouracile
Indication
Disease Entry ICD 11 Status REF
Hyperthyroidism 5A02 Approved [1]
Thyroid crisis Approved [2]
Therapeutic Class
Antithyroid Agents
Cross-matching ID
PubChem CID
657298
ChEBI ID
CHEBI:8502
CAS Number
51-52-5
TTD ID
D00MIN
ACDINA ID
D00566

Full List of Drug Formulations Containing This Drug

Propylthiouracil 50 mg tablet
Company Formulation ID FDA Description
DAVA Pharmaceuticals F18216 Sodium benzoate; Docusate sodium; Magnesium stearate; Cellulose, microcrystalline; Sodium glycolate; Starch, corn
American Health Packaging F18220 Sodium benzoate; Docusate sodium; Magnesium stearate; Microcrystalline cellulose; Sodium glycolate; Starch, corn
Clinical Solutions Wholesale F18217 Docusate sodium; Magnesium stearate; Water; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
Actavis Pharma; Avera McKennan Hospital; Cardinal Health; RemedyRepack F18219 Lactose monohydrate; Magnesium stearate; Povidone; Silicon dioxide; Starch, corn
NCS HealthCare of KY, Inc dba Vangard Labs F18218 Lactose monohydrate; Magnesium stearate; Povidone; Colloidal silicon dioxide; Starch, corn; Starch, corn
Cardinal Health F18215 Anhydrous lactose; Magnesium stearate; Cellulose, microcrystalline; Starch, corn
Rebel Distributors; RemedyRepack; West-Ward Pharmaceticals F18221 Anhydrous lactose; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Formulation(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6650).
2 Propylthiouracil FDA Label